Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 1
2005 1
2006 1
2007 3
2008 2
2009 1
2010 1
2011 1
2012 1
2013 1
2014 4
2015 5
2016 2
2018 1
2019 2
2020 5
2021 7
2022 5
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Antibody-mediated SARS-CoV-2 entry in cultured cells.
Kibria MG, Lavine CL, Tang W, Wang S, Gao H, Shi W, Zhu H, Voyer J, Rits-Volloch S, Keerti, Bi C, Peng H, Wesemann DR, Lu J, Xie H, Seaman MS, Chen B. Kibria MG, et al. Among authors: lavine cl. EMBO Rep. 2023 Dec 6;24(12):e57724. doi: 10.15252/embr.202357724. Epub 2023 Nov 2. EMBO Rep. 2023. PMID: 38277394 Free article.
Structural and functional characteristics of the SARS-CoV-2 Omicron subvariant BA.2 spike protein.
Zhang J, Tang W, Gao H, Lavine CL, Shi W, Peng H, Zhu H, Anand K, Kosikova M, Kwon HJ, Tong P, Gautam A, Rits-Volloch S, Wang S, Mayer ML, Wesemann DR, Seaman MS, Lu J, Xiao T, Xie H, Chen B. Zhang J, et al. Among authors: lavine cl. Nat Struct Mol Biol. 2023 Jul;30(7):980-990. doi: 10.1038/s41594-023-01023-6. Epub 2023 Jul 10. Nat Struct Mol Biol. 2023. PMID: 37430064
Autologous neutralizing antibodies increase with early antiretroviral therapy and shape HIV rebound after treatment interruption.
Esmaeilzadeh E, Etemad B, Lavine CL, Garneau L, Li Y, Regan J, Wong C, Sharaf R, Connick E, Volberding P, Sagar M, Seaman MS, Li JZ. Esmaeilzadeh E, et al. Among authors: lavine cl. Sci Transl Med. 2023 May 10;15(695):eabq4490. doi: 10.1126/scitranslmed.abq4490. Epub 2023 May 10. Sci Transl Med. 2023. PMID: 37163616 Free PMC article.
Structural and functional impact by SARS-CoV-2 Omicron spike mutations.
Zhang J, Cai Y, Lavine CL, Peng H, Zhu H, Anand K, Tong P, Gautam A, Mayer ML, Rits-Volloch S, Wang S, Sliz P, Wesemann DR, Yang W, Seaman MS, Lu J, Xiao T, Chen B. Zhang J, et al. Among authors: lavine cl. Cell Rep. 2022 Apr 26;39(4):110729. doi: 10.1016/j.celrep.2022.110729. Epub 2022 Apr 11. Cell Rep. 2022. PMID: 35452593 Free PMC article.
Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production.
Chen Y, Zuiani A, Fischinger S, Mullur J, Atyeo C, Travers M, Lelis FJN, Pullen KM, Martin H, Tong P, Gautam A, Habibi S, Bensko J, Gakpo D, Feldman J, Hauser BM, Caradonna TM, Cai Y, Burke JS, Lin J, Lederer JA, Lam EC, Lavine CL, Seaman MS, Chen B, Schmidt AG, Balazs AB, Lauffenburger DA, Alter G, Wesemann DR. Chen Y, et al. Among authors: lavine cl. Cell. 2020 Dec 10;183(6):1496-1507.e16. doi: 10.1016/j.cell.2020.10.051. Epub 2020 Nov 3. Cell. 2020. PMID: 33171099 Free PMC article.
Structural and functional characteristics of SARS-CoV-2 Omicron subvariant BA.2 spike.
Zhang J, Tang W, Gao H, Lavine CL, Shi W, Peng H, Zhu H, Anand K, Kosikova M, Kwon HJ, Tong P, Gautam A, Rits-Volloch S, Wang S, Mayer ML, Wesemann DR, Seaman MS, Lu J, Xiao T, Xie H, Chen B. Zhang J, et al. Among authors: lavine cl. bioRxiv [Preprint]. 2022 Apr 28:2022.04.28.489772. doi: 10.1101/2022.04.28.489772. bioRxiv. 2022. PMID: 35547850 Free PMC article. Updated. Preprint.
Memory B cell repertoire for recognition of evolving SARS-CoV-2 spike.
Tong P, Gautam A, Windsor I, Travers M, Chen Y, Garcia N, Whiteman NB, McKay LGA, Lelis FJN, Habibi S, Cai Y, Rennick LJ, Duprex WP, McCarthy KR, Lavine CL, Zuo T, Lin J, Zuiani A, Feldman J, MacDonald EA, Hauser BM, Griffths A, Seaman MS, Schmidt AG, Chen B, Neuberg D, Bajic G, Harrison SC, Wesemann DR. Tong P, et al. Among authors: lavine cl. bioRxiv [Preprint]. 2021 Mar 10:2021.03.10.434840. doi: 10.1101/2021.03.10.434840. bioRxiv. 2021. PMID: 33758863 Free PMC article. Updated. Preprint.
Memory B cell repertoire for recognition of evolving SARS-CoV-2 spike.
Tong P, Gautam A, Windsor IW, Travers M, Chen Y, Garcia N, Whiteman NB, McKay LGA, Storm N, Malsick LE, Honko AN, Lelis FJN, Habibi S, Jenni S, Cai Y, Rennick LJ, Duprex WP, McCarthy KR, Lavine CL, Zuo T, Lin J, Zuiani A, Feldman J, MacDonald EA, Hauser BM, Griffths A, Seaman MS, Schmidt AG, Chen B, Neuberg D, Bajic G, Harrison SC, Wesemann DR. Tong P, et al. Among authors: lavine cl. Cell. 2021 Sep 16;184(19):4969-4980.e15. doi: 10.1016/j.cell.2021.07.025. Epub 2021 Jul 23. Cell. 2021. PMID: 34332650 Free PMC article.
A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent.
Xiao T, Lu J, Zhang J, Johnson RI, McKay LGA, Storm N, Lavine CL, Peng H, Cai Y, Rits-Volloch S, Lu S, Quinlan BD, Farzan M, Seaman MS, Griffiths A, Chen B. Xiao T, et al. Among authors: lavine cl. Nat Struct Mol Biol. 2021 Feb;28(2):202-209. doi: 10.1038/s41594-020-00549-3. Epub 2021 Jan 11. Nat Struct Mol Biol. 2021. PMID: 33432247 Free PMC article.
Vaccine breakthrough infection leads to distinct profiles of neutralizing antibody responses by SARS-CoV-2 variant.
Seaman MS, Siedner MJ, Boucau J, Lavine CL, Ghantous F, Liew MY, Mathews JI, Singh A, Marino C, Regan J, Uddin R, Choudhary MC, Flynn JP, Chen G, Stuckwisch AM, Lipiner T, Kittilson A, Melberg M, Gilbert RF, Reynolds Z, Iyer SL, Chamberlin GC, Vyas TD, Vyas JM, Goldberg MB, Luban J, Li JZ, Barczak AK, Lemieux JE. Seaman MS, et al. Among authors: lavine cl. JCI Insight. 2022 Oct 10;7(19):e159944. doi: 10.1172/jci.insight.159944. JCI Insight. 2022. PMID: 36214224 Free PMC article.
41 results